Organigram Global Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Organigram Global Inc's ROI in the fourth quarter of 2025?
Organigram Global Inc recorded a cumulative net loss of $-19 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -5.68%.

Within the Healthcare sector 252 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 2985.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Sep 30 2024) IV. Quarter
Y / Y Investment Change TTM	22.99 %	24.12 %	25.38 %	26.81 %	28.44 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	334	334	334	334	272
Return On Investment (TTM)	-5.68 %	-10.93 %	-11.5 %	-12.12 %	-12.82 %
OGI's Overall Ranking	# 2985	#	#	#	#
Seq. Investment Change TTM	4.9 %	5.16 %	5.44 %	5.75 %	5.86 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-19	-35	-35	-35	-35

OGI Company Profile >> Back to OGI Roi Comparisons >> See Annual OGI Return On Investment

Return On Investment OGI's Ranking
Within:	No.
Industry	# 85
Sector	# 253
Overall	# 2985

Return On Investment Statistics
High	Average	Low
-5.68 %	-8.06 %	-12.82 %
(Sep 30 2025)		(Sep 30 2024)

Financial Statements
Organigram Global Inc's IV. Quarter Investments	$ 334 Millions	OGI's Balance sheet
Organigram Global Inc's IV. Quarter Income	$ -19 Millions	Quarterly OGI's Income Statement
OGI's Income by Division		See OGI's Income by Division

OGI Annual Return On Investment	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023	(Aug 31 2022) 2022	(Aug 31 2021) 2021
Total Investments in Millions	334	272	211	399	418
Y / Y Investment Growth	22.99 %	28.44 %	-46.96 %	-4.61 %	34.14 %
Net Income in Millions	-19	-35	-11	-11	-103
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-5.68 %	-12.82 %	-5.17 %	-2.82 %	-24.68 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OGI's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OGI's Competitors
Subscribers only: Roi for Organigram Global Inc's Suppliers
Subscribers only: Return On Investment for OGI's Customers

Other Ratios
OGI's Roa	OGI's Inventory Turnover Ratio	OGI's Growth Rates	OGI's Dividend Statistics
	OGI's Profitability Ratios	OGI's Asset Turnover Ratio	OGI's Dividend Growth
OGI's Roe	OGI's Valuation Ratios	OGI's Financial Strength Ratios	OGI's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector

ROI

Date modified: 2026-06-22T16:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.